2019 Scientific Sessions

What Is the Role for Cangrelor or GP IIB/IIIA Inhibitors in Today’s Practice?

Prospero B. Gogo, M.D., University of Vermont Medical Center, Burlington, VT
Prospero B. Gogo, M.D., University of Vermont Medical Center, Burlington, VT

Learning Objectives:
  1. Become familiar with emerging percutaneous ventricular support technologies and ongoing clinical trials.